A quietly curated catalogue of high-purity compounds — anabolic steroids, psychedelic drugs and research chemicals — each batch documented, tested and dispatched discreetly to laboratories worldwide.
Navigate the catalogue by research area. Every listing carries its own purity report, storage guidance and batch reference.
A rotating selection from the catalogue, chosen for purity, documentation and demand.
4-MMC (Mephedrone) is a synthetic stimulant drug of the amphetamine and cathinone classes. It is chemically similar to the cathinone compounds naturally found in the khat plant of eastern Africa. Mephedrone produces effects similar to MDMA, amphetamine, and cocaine, including euphoria, stimulation, and empathogenic effects.
3-MMC (3-Methylmethcathinone) is a synthetic cathinone stimulant closely related to mephedrone (4-MMC). It is a designer drug that produces stimulant and empathogenic effects. 3-MMC belongs to the substituted cathinone family and acts as a monoamine releasing agent.
U-47700 is a synthetic opioid analgesic drug developed by a team at Upjohn in the 1970s. It is a selective agonist of the mu-opioid receptor with approximately 7.5 times the potency of morphine. U-47700 is used as a reference standard in forensic and analytical chemistry research applications.
4-AcO-DMT (O-Acetylpsilocin, 4-Acetoxy-DMT, Psilacetin) is a synthetically produced psychedelic tryptamine. It is the acetylated form of the psilocybin mushroom alkaloid psilocin. Originally patented in 1963 by Sandoz Ltd. via Albert Hofmann & Franz Troxler. Its psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. In the body, 4-AcO-DMT is thought to be deacetylated into psilocin during first pass metabolism.
5F-SGT-151 (5F-CUMYL-PeGaCLONE) is one of the new generation of novel synthetic cannabinoids. It is a cannabinoid designer drug with pronounced physiological and psychoactive effects and has the molecular formula C22H26FN3O. Synthetic cannabinoid 5F-SGT-151 can show high affinity for the peripheral receptors of cannabinoid CB1 and CB2. Designed for research and forensic applications.
1-TEST CYP 200 – Manufactured by Dragon Pharma. Active substance: Dihydroboldenone Cypionate. Strength: 200 mg. Unit: 10 mL vial (200 mg/mL). This product is produced and stored under controlled conditions to maintain batch consistency and is suitable for identity confirmation, purity profiling, and reference-spectrum generation in forensic, clinical-research, and analytical-chemistry workflows. It is not intended for human or veterinary administration, diagnostic use, cosmetic application, or consumption of any kind. Handling should be restricted to qualified personnel in a properly equipped laboratory. Use appropriate personal protective equipment, containment, and disposal procedures, and ensure full compliance with all local, national, and institutional regulations governing controlled, scheduled, or pharmaceutical-reference substances.
Each incoming batch is independently assayed before it is listed. No batch ships without a report.
Reference numbers tie every vial back to its analytical certificate and storage conditions.
Neutral packaging, temperature-aware handling and tracked delivery across all major regions.
“The consistency between batches is what keeps us here. Documentation arrives before the parcel does.”
Join the laboratories and research groups that rely on ChemicalsSite for documented, high-purity compounds.